Q2 2026 13F · SEC CIK 1013538
Edgar Lomax Co/va
Investment managerFiled 2026-08-13 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $1.3B
- Reported positions
- 58
- Top holdings a year, 3 yrs
- +16.7%
- Average holding period
- 5.3 yrs
Edgar Lomax Co/va is an investment manager that reported 58 positions worth $1.3B in its Q2 2026 13F, filed 2026-08-13. Its largest holdings were Target Corp (TGT, 5.7%), Unitedhealth Group Inc (UNH, 5.6%), Cvs Health Corp (CVS, 5.1%). A portfolio copying its top holdings returned 16.7% a year over the last 3 years, against 20.4% for the S&P 500.
Edgar Lomax Co/va holdings largest 50 of 58 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
What Edgar Lomax Co/va bought and sold in Q2 2026, against Q1 2026.
New positions
Q1 2026's filing was too long to tell new positions apart.
Added to
No position grew by more than 5%.
Reduced
- COP Conocophillips-9.7% shares
- XOM Exxon Mobil Corp-8.7% shares
- CVX Chevron Corporation-8.6% shares
- SPG Simon Ppty Group Inc New-8.4% shares
- AMT American Tower Corp-8.3% shares
- PEP Pepsico Inc-8.3% shares
- GM General Mtrs Co-8.3% shares
- SBUX Starbucks Corp-8.3% shares
Left the top 50
- IVE Ishares Trwas 0.3%
Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.
How the holdings did against the S&P 500.
- 1 year
- +33.3% /yr
- S&P 500 +20.1%
- 3 years
- +16.7% /yr
- S&P 500 +20.4%
- 5 years
- +9.6% /yr
- S&P 500 +11.6%
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $1.3B | 58 |
| Q1 2026 | $1.4B | 56 |
| Q4 2025 | $1.3B | 64 |
| Q3 2025 | $1.3B | 58 |
| Q2 2025 | $1.6B | 58 |
| Q1 2025 | $1.6B | 58 |
| Q4 2024 | $1.6B | 68 |
| Q3 2024 | $1.6B | 65 |
| Q2 2024 | $1.5B | 65 |
| Q1 2024 | $1.6B | 63 |
| Q4 2023 | $1.5B | 57 |
| Q3 2023 | $1.5B | 57 |
Questions about Edgar Lomax Co/va's portfolio
What stocks does Edgar Lomax Co/va own?
Edgar Lomax Co/va's latest 13F, for Q2 2026 and filed Aug 13, 2026, lists 58 positions worth $1.3B. The largest are Target Corp (TGT) at 5.7%, Unitedhealth Group Inc (UNH) at 5.6%, Cvs Health Corp (CVS) at 5.1%, Fedex Corp (FDX) at 4.6% and Mondelez International (MDLZ) at 4.0%.
What did Edgar Lomax Co/va buy last quarter?
Edgar Lomax Co/va opened no new positions and grew none by more than 5% among its largest holdings in Q2 2026.
What did Edgar Lomax Co/va sell last quarter?
In Q2 2026, Edgar Lomax Co/va cut from its top 50 Ishares Tr (IVE), Conocophillips (COP) (-9.7% shares), Exxon Mobil Corp (XOM) (-8.7% shares) and Chevron Corporation (CVX) (-8.6% shares), compared with its Q1 2026 filing.
How has Edgar Lomax Co/va's portfolio performed?
A portfolio copying Edgar Lomax Co/va's 20 largest 13F holdings each quarter, from the day each filing was public, returned +16.7% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +33.3% against +20.1%. Over 5 years: +9.6% a year against +11.6%.
When is Edgar Lomax Co/va's next 13F filing due?
13F filings are due 45 days after each quarter ends. Edgar Lomax Co/va's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.